Non-Hodgkin’s Lymphoma Survival Rate

As mentioned before, Non-Hodgkin’s Lymphoma is a treatable condition, provided that it is accurately diagnosed by the doctor at an early stage. However, the risk of developing Non-Hodgkin’s Lymphoma increases with age, which definitely affects the survival rate particularly considering the overall health condition of the diagnosed individual. In addition, since it has several subtypes, accurate diagnosis is essential to ensure effective treatment.

The 5-year survival rate is a measure of the percentage of patients that are expected to live for five years following their cancer diagnosis. The 5-year survival rate is also relative, by representing the percentage of patients who are as likely as people who are not diagnosed with cancer to live for five years. This rate also varies slightly according to the gender. In England and Wales, statistics show that 80% of men survive Non-Hodgkin’s Lymphoma for at least one year whereas the percentage is 79% for women. The 5-year relative survival rate is around 68% for men and 70% for women, whereas the 10-year survival rate is 62% for men and 64% for women.

References:



https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/non-hodgkin-lymphoma/survival#heading-Zero